⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

Official Title: Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen (Relapsing-remitting Multiple Sclerosis and Active Secondary Progressive Multiple Sclerosis)

Study ID: NCT04940065

Interventions

Kesimpta

Study Description

Brief Summary: This study is an uncontrolled, central registration system, open-label, multicenter observational study in patients using Kesimpta for the labeled indication.

Detailed Description: This is a primary data collection-based special drug-use surveillance to be conducted in accordance with the GPSP ordinance. Observational period will last 24 months from the start of treatment with Kesimpta.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Novartis Investigative Site, Ichinomiya, Aichi, Japan

Novartis Investigative Site, Nagakute-city, Aichi, Japan

Novartis Investigative Site, Nagoya-city, Aichi, Japan

Novartis Investigative Site, Nagoya, Aichi, Japan

Novartis Investigative Site, Nagoya, Aichi, Japan

Novartis Investigative Site, Tokoname, Aichi, Japan

Novartis Investigative Site, Toyohashi, Aichi, Japan

Novartis Investigative Site, Hachinohe, Aomori, Japan

Novartis Investigative Site, Hachinohe, Aomori, Japan

Novartis Investigative Site, Hirosaki, Aomori, Japan

Novartis Investigative Site, Ichikawa, Chiba, Japan

Novartis Investigative Site, Narita, Chiba, Japan

Novartis Investigative Site, Yachiyo city, Chiba, Japan

Novartis Investigative Site, Toon city, Ehime, Japan

Novartis Investigative Site, Fukuoka city, Fukuoka, Japan

Novartis Investigative Site, Fukuoka-city, Fukuoka, Japan

Novartis Investigative Site, Iizuka-city, Fukuoka, Japan

Novartis Investigative Site, Kitakyushu-city, Fukuoka, Japan

Novartis Investigative Site, Kurume city, Fukuoka, Japan

Novartis Investigative Site, Omuta, Fukuoka, Japan

Novartis Investigative Site, Gifu-city, Gifu, Japan

Novartis Investigative Site, Maebashi city, Gunma, Japan

Novartis Investigative Site, Maebashi, Gunma, Japan

Novartis Investigative Site, Fukuyama, Hiroshima, Japan

Novartis Investigative Site, Hiroshima-city, Hiroshima, Japan

Novartis Investigative Site, Asahikawa, Hokkaido, Japan

Novartis Investigative Site, Hakodate, Hokkaido, Japan

Novartis Investigative Site, Sapporo city, Hokkaido, Japan

Novartis Investigative Site, Sapporo city, Hokkaido, Japan

Novartis Investigative Site, Sapporo, Hokkaido, Japan

Novartis Investigative Site, Sapporo, Hokkaido, Japan

Novartis Investigative Site, Sunagawa, Hokkaido, Japan

Novartis Investigative Site, Kobe-city, Hyogo, Japan

Novartis Investigative Site, Kobe-shi, Hyogo, Japan

Novartis Investigative Site, Mito-city, Ibaraki, Japan

Novartis Investigative Site, Tsuchiura, Ibaraki, Japan

Novartis Investigative Site, Ichinoseki, Iwate, Japan

Novartis Investigative Site, Ichinoseki, Iwate, Japan

Novartis Investigative Site, Morioka, Iwate, Japan

Novartis Investigative Site, Kagoshima city, Kagoshima, Japan

Novartis Investigative Site, Kanoya, Kagoshima, Japan

Novartis Investigative Site, Kawasaki-city, Kanagawa, Japan

Novartis Investigative Site, Sagamihara, Kanagawa, Japan

Novartis Investigative Site, Yokohama city, Kanagawa, Japan

Novartis Investigative Site, Yokohama-city, Kanagawa, Japan

Novartis Investigative Site, Yokohama-city, Kanagawa, Japan

Novartis Investigative Site, Yokohama, Kanagawa, Japan

Novartis Investigative Site, Nankoku city, Kochi, Japan

Novartis Investigative Site, Kyoto-city, Kyoto, Japan

Novartis Investigative Site, Kyoto-city, Kyoto, Japan

Novartis Investigative Site, Kyoto-city, Kyoto, Japan

Novartis Investigative Site, Kesennuma, Miyagi, Japan

Novartis Investigative Site, Sendai city, Miyagi, Japan

Novartis Investigative Site, Sendai city, Miyagi, Japan

Novartis Investigative Site, Nagano-city, Nagano, Japan

Novartis Investigative Site, Nagano-city, Nagano, Japan

Novartis Investigative Site, Sasebo-city, Nagasaki, Japan

Novartis Investigative Site, Kashihara city, Nara, Japan

Novartis Investigative Site, Tenri, Nara, Japan

Novartis Investigative Site, Niigata-city, Niigata, Japan

Novartis Investigative Site, Kurashiki-city, Okayama, Japan

Novartis Investigative Site, Okayama-city, Okayama, Japan

Novartis Investigative Site, Fujiidera, Osaka, Japan

Novartis Investigative Site, Moriguchi, Osaka, Japan

Novartis Investigative Site, Osaka Sayama, Osaka, Japan

Novartis Investigative Site, Osaka-city, Osaka, Japan

Novartis Investigative Site, Osaka-city, Osaka, Japan

Novartis Investigative Site, Osaka-city, Osaka, Japan

Novartis Investigative Site, Sakai, Osaka, Japan

Novartis Investigative Site, Suita, Osaka, Japan

Novartis Investigative Site, Kawagoe, Saitama, Japan

Novartis Investigative Site, Koshigaya, Saitama, Japan

Novartis Investigative Site, Wako-city, Saitama, Japan

Novartis Investigative Site, Ohtsu-city, Shiga, Japan

Novartis Investigative Site, Omihachiman, Shiga, Japan

Novartis Investigative Site, Izumo-city, Shimane, Japan

Novartis Investigative Site, Hamamatsu-city, Shizuoka, Japan

Novartis Investigative Site, Oyama, Tochigi, Japan

Novartis Investigative Site, Shimotsuga Gun, Tochigi, Japan

Novartis Investigative Site, Shimotsuke, Tochigi, Japan

Novartis Investigative Site, Bunkyo ku, Tokyo, Japan

Novartis Investigative Site, Bunkyo ku, Tokyo, Japan

Novartis Investigative Site, Edogawa, Tokyo, Japan

Novartis Investigative Site, Fuchu, Tokyo, Japan

Novartis Investigative Site, Kiyose-city, Tokyo, Japan

Novartis Investigative Site, Minato-ku, Tokyo, Japan

Novartis Investigative Site, Nakano, Tokyo, Japan

Novartis Investigative Site, Shinjuku-ku, Tokyo, Japan

Novartis Investigative Site, Shinjuku-ku, Tokyo, Japan

Novartis Investigative Site, Toyama-city, Toyama, Japan

Novartis Investigative Site, Kudamatsu, Yamaguchi, Japan

Novartis Investigative Site, Shunan-city, Yamaguchi, Japan

Novartis Investigative Site, Ube, Yamaguchi, Japan

Novartis Investigative Site, Aomori, , Japan

Novartis Investigative Site, Chiba, , Japan

Novartis Investigative Site, Kagoshima, , Japan

Novartis Investigative Site, Kyoto, , Japan

Novartis Investigative Site, Niigata, , Japan

Novartis Investigative Site, Oita, , Japan

Novartis Investigative Site, Osaka, , Japan

Novartis Investigative Site, Osaka, , Japan

Novartis Investigative Site, Saitama, , Japan

Novartis Investigative Site, Wakayama, , Japan

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: